CERO THERAPEUTICS HOLDINGS, INC. — Form D

CERO THERAPEUTICS HOLDINGS, INC. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-06. The offering totals $8.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2025-05-06
Form: D
Accession: 0001470831-25-000015
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $8.0M
Amount sold: $5.0M
Remaining: $3.0M
Investors: 5
Date of first sale: 2025-04-22
Security types: equity
Revenue range: No Revenues
SEC file number: 021-545301

Issuer

Name: CERO THERAPEUTICS HOLDINGS, INC.
CIK: 0001870404
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
Phone: 650-407-2376

Officers, directors & promoters (19)

Name	Role	Location
Brian G Atwood	Director	Gaithersburg, MD
Michael G Byrnes	Director	South San Francisco, CA
Chris Ehrlich	Director	South San Francisco, CA
Kathleen G LaPorte	Director	South San Francisco, CA
Shami G Patel	Director	South San Francisco, CA
Lindsey G Rolfe	Director	South San Francisco, CA
Chris Ehrlich	Executive Officer	South San Francisco, CA
Andrew Albert Kucharchuk	Executive Officer	South San Francisco, CA
Kristen Albert Pierce	Executive Officer	South San Francisco, CA
Michael Byrnes	Director	Philadelphia, PA
Michael Albert Byrnes	Director	South San Francisco, CA
Brian Atwood	Director	South San Francisco, CA
Brian Atwood	Executive Officer	South San Francisco, CA
Lindsey Albert Rolfe	Director	South San Francisco, CA
Chris Albert Ehrlich	Director	South San Francisco, CA
Chris Albert Ehrlich	Executive Officer	South San Francisco, CA
Kathleen Albert LaPorte	Director	South San Francisco, CA
Lindsey Rolfe	Director	South San Francisco, CA
Robyn Rapaport	Director	South San Francisco, CA

Other filings by this issuer (2)

Filed	Form	Offering	Sold
2024-10-04	D	$1.3M	$1.3M
2024-02-23	D	$10.2M	$10.2M

More